Timothy Sheahan, PhD
Dr. Sheahan's research aims to explore the host pathogen interface in order to discover new methods for viral control. Viruses are parasites and require the host's machinery to propagate and spread. For the past 12 years, Dr. Sheahan has been studying the molecular mechanisms of viral pathogenesis in hopes of discovering viral and/or host proteins to target for antiviral therapy.
After gaining expertise in SARS Coronavirus pathogenesis with Dr. Ralph Baric at UNC-Chapel Hill, Dr. Sheahan moved to New York City for a postdoctoral fellowship studying the hepatitis C virus with Dr. Charles Rice at The Rockefeller University. After a year learning antiviral drug development at GlaxoSmithKline, Dr. Sheahan enthusiastically joined the Gillings School as research faculty in July 2015
PhD, Microbiology / Immunology, University of North Carolina at Chapel Hill, 2008
BS, Microbiology / Water Resource Management, University of New Hampshire, 1999